NCT03176368

Brief Summary

This study will seek to assess the experience of using of coconut oil as an approach to managing radiation-induced xerostomia in patients previously treated for cancer in the head and neck. There is a high prevalence of radiation-induced xerostomia in this patient population, and the condition has significant negative impact on patients' quality of life. There is currently no agreed-upon standard of care for the treatment of this condition. Anecdotal evidence from patients and both physicians and allied healthcare providers suggests improvement in this condition with the use of coconut oil, but this has not previously been formally studied. We therefore propose a case series study to formally assess the tolerability and efficacy of coconut oil as an approach to managing radiation-induced xerostomia.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 5, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

October 5, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2018

Completed
Last Updated

April 17, 2018

Status Verified

April 1, 2018

Enrollment Period

8 months

First QC Date

May 1, 2017

Last Update Submit

April 13, 2018

Conditions

Keywords

dry mouthcoconut oilradiation

Outcome Measures

Primary Outcomes (1)

  • Subjective benefit

    Our primary outcome of interest will be descriptive in nature, namely whether patients find subjective benefit from the use of coconut oil, as evidenced by its continued use throughout the study period. This will be appraised qualitatively by analyzing diary entries.

    3 months

Secondary Outcomes (5)

  • Quality of Life

    3 months

  • Change in Activities of Daily Living as assessed clinically at follow up appointment and as measured by the Xerostomia-related quality of life scale (XeQOLS).

    3 months

  • Speech as assessed clinically at follow up appointment and as measured by the Xerostomia-related quality of life scale (XeQOLS).

    3 months

  • Dysphagia as assessed clinically at follow up appointment and by way of the XeQOLS.

    3 months

  • Coconut Oil

    2 weeks or more

Study Arms (1)

Coconut Oil

EXPERIMENTAL

Through a interventional/cohort design, we propose to study the experience of coconut oil over a three month period, allowing patients to use Biotene© oral lubricant (or another product of their choice) as an alternative to coconut oil if they so prefer.

Other: Coconut Oil

Interventions

Coconut Oil

Also known as: Natural Product
Coconut Oil

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has completed treatment for head and neck cancer at least 18 months prior to entry to the study.
  • Patient has experienced xerostomia following completion of radiation treatment.
  • Patient has received external beam radiation at a dose of at least 50 Gy to the head and neck.
  • Patients able to read / understand English.
  • Patients who are competent/willing to consent to the study.
  • Patients willing to comply with protocol and study schedule.

You may not qualify if:

  • Patient currently undergoing treatment for head and neck cancer.
  • Patient has previously used coconut oil for the treatment of xerostomia.
  • Patient with allergy/sensitivity to coconut.
  • Patient cannot read/ understand English.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ottawa Hospital

Ottawa, Ontario, K1H8L6, Canada

Location

MeSH Terms

Conditions

Xerostomia

Interventions

Coconut OilBiological Products

Condition Hierarchy (Ancestors)

Salivary Gland DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dietary FatsFatsLipidsPlant OilsOilsComplex Mixtures

Study Officials

  • Stephanie Johnson-Obaseki, MD

    The Ottawa Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2017

First Posted

June 5, 2017

Study Start

October 5, 2017

Primary Completion

June 15, 2018

Study Completion

September 15, 2018

Last Updated

April 17, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations